Across TCGA pan-cancer cohorts, ELOA3DP Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ELOA3DP data layer compared with 11 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher ELOA3DP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ELOA3DP expression acts as an unfavorable survival marker.

COAD are the cancer types where ELOA3DP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.001	0.871	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: ELOA3DP tumor-vs-normal RNA expression · all ELOA3DP data types